Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 12818902.
- Also identified by PMC identifier 1763182.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Blood fatty acid status and visual function of 20 treated hyperphenylalaninemic (HPA) children, randomly allocated into two groups to receive supplementation of either long chain polyunsaturated fatty acids (LCPUFA), including docosahexaenoic acid (DHA), or placebo for 12 months, have been investigated three years after the end of the treatment. Although in the LCPUFA group blood DHA levels and P100 wave latency improved at the end of supplementation, they had returned to baseline after three years.
Medical subject headings
- Dietary Supplements
- Fatty Acids, Unsaturated
- Phenylketonurias